Christopher Larkin

2.4k total citations
18 papers, 599 citations indexed

About

Christopher Larkin is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering. According to data from OpenAlex, Christopher Larkin has authored 18 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Biomedical Engineering. Recurrent topics in Christopher Larkin's work include Protein purification and stability (8 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Christopher Larkin is often cited by papers focused on Protein purification and stability (8 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Christopher Larkin collaborates with scholars based in United States, Poland and Japan. Christopher Larkin's co-authors include Susanne Schoch, Pascal S. Kaeser, Thomas C. Südhof, György Lónárt, David J. Linden, Wai Keen Chung, Min Zhu, David J. Robbins, Nabila Aboulaich and James B. McGivney and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Analytical Chemistry.

In The Last Decade

Christopher Larkin

16 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Larkin United States 11 404 140 118 84 80 18 599
Imke Oltmann‐Norden Germany 11 432 1.1× 124 0.9× 57 0.5× 96 1.1× 23 0.3× 13 603
Catherine K. Xu United Kingdom 17 466 1.2× 101 0.7× 44 0.4× 77 0.9× 27 0.3× 29 1.0k
Elizabeth K. M. Johnstone Australia 12 527 1.3× 188 1.3× 61 0.5× 34 0.4× 23 0.3× 18 784
Marcia Roy United Kingdom 12 286 0.7× 85 0.6× 43 0.4× 63 0.8× 30 0.4× 13 489
Brent Larsen United States 14 303 0.8× 103 0.7× 44 0.4× 73 0.9× 57 0.7× 33 645
Jendrik Schöppe Switzerland 11 477 1.2× 165 1.2× 124 1.1× 23 0.3× 36 0.5× 15 603
Rob van der Kant Belgium 13 623 1.5× 86 0.6× 159 1.3× 45 0.5× 30 0.4× 17 707
Veronica Pessino United States 9 417 1.0× 133 0.9× 56 0.5× 101 1.2× 13 0.2× 10 617
D.B. Langley Australia 14 741 1.8× 115 0.8× 100 0.8× 52 0.6× 16 0.2× 26 1.1k
Hiroyuki Matsumoto United States 16 344 0.9× 187 1.3× 65 0.6× 41 0.5× 82 1.0× 39 701

Countries citing papers authored by Christopher Larkin

Since Specialization
Citations

This map shows the geographic impact of Christopher Larkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Larkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Larkin more than expected).

Fields of papers citing papers by Christopher Larkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Larkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Larkin. The network helps show where Christopher Larkin may publish in the future.

Co-authorship network of co-authors of Christopher Larkin

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Larkin. A scholar is included among the top collaborators of Christopher Larkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Larkin. Christopher Larkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Larkin, Christopher, Sabeel P. Valappil, & Navaneethan Palanisamy. (2025). Global prevalence of nitrofurantoin-resistant uropathogenic Escherichia coli (UPEC) in humans: a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy. 80(10). 2609–2621.
2.
Côté, Olivier, et al.. (2019). A rapid lateral flow immunoassay for identity testing of biotherapeutics. Journal of Immunological Methods. 474. 112666–112666. 9 indexed citations
3.
McGivney, James B., Andrew T. Csordas, Faye Walker, et al.. (2018). Strategy for Generating Sequence-Defined Aptamer Reagent Sets for Detecting Protein Contaminants in Biotherapeutics. Analytical Chemistry. 90(5). 3262–3269. 7 indexed citations
5.
Burke, Meghan C., Yuri A. Mirokhin, Dmitrii V. Tchekhovskoi, et al.. (2017). The Hybrid Search: A Mass Spectral Library Search Method for Discovery of Modifications in Proteomics. Journal of Proteome Research. 16(5). 1924–1935. 51 indexed citations
6.
Manthei, Kelly A., Joomi Ahn, Alisa Glukhova, et al.. (2017). A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I. Journal of Biological Chemistry. 292(49). 20313–20327. 32 indexed citations
7.
Zhu, Guijie, Liangliang Sun, Christopher Larkin, et al.. (2016). Quantitative analysis of the supernatant from host and transfected CHO cells using iTRAQ 8‐plex technique. Biotechnology and Bioengineering. 113(10). 2140–2148. 7 indexed citations
9.
Paidi, Santosh Kumar, Soumik Siddhanta, Robert Strouse, et al.. (2016). Rapid Identification of Biotherapeutics with Label-Free Raman Spectroscopy. Analytical Chemistry. 88(8). 4361–4368. 29 indexed citations
10.
Kubiak, Robert, Nancy Lee, Yuan Zhu, et al.. (2016). Storage Conditions of Conjugated Reagents Can Impact Results of Immunogenicity Assays. Journal of Immunology Research. 2016. 1–10. 19 indexed citations
11.
Zhu, Guijie, et al.. (2015). Capillary zone electrophoresis tandem mass spectrometry detects low concentration host cell impurities in monoclonal antibodies. Electrophoresis. 37(4). 616–622. 27 indexed citations
12.
Aboulaich, Nabila, et al.. (2014). A novel approach to monitor clearance of host cell proteins associated with monoclonal antibodies. Biotechnology Progress. 30(5). 1114–1124. 111 indexed citations
13.
Khurana, Surender, Christopher Larkin, Swati Verma, et al.. (2011). Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines. Vaccine. 29(34). 5657–5665. 34 indexed citations
14.
Larkin, Christopher, Rembrandt J. F. Haft, Matthew J. Harley, Beth Traxler, & Joel F. Schildbach. (2007). Roles of Active Site Residues and the HUH Motif of the F Plasmid TraI Relaxase. Journal of Biological Chemistry. 282(46). 33707–33713. 26 indexed citations
15.
Weldon, John E., Michael E. Rodgers, Christopher Larkin, & Robert Schleif. (2006). Structure and properties of a truely apo form of AraC dimerization domain. Proteins Structure Function and Bioinformatics. 66(3). 646–654. 30 indexed citations
16.
Lónárt, György, Susanne Schoch, Pascal S. Kaeser, et al.. (2003). Phosphorylation of RIM1α by PKA Triggers Presynaptic Long-Term Potentiation at Cerebellar Parallel Fiber Synapses. Cell. 115(1). 49–60. 192 indexed citations
17.
Thomson, Virgil, et al.. (1999). From the steeples and the mountains.
18.
Cotter, David, Nobuyuki Takei, Christopher Larkin, et al.. (1993). Does prenatal exposure to influenza induce pyramidal cell disarray in mice?. Schizophrenia Research. 9(2-3). 147–147. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026